Effect of Empagliflozin in Prediabetes

Phase 3

Recruiting

• Conditions: Condition 1: Impaired fasting glucose. Condition 2: Impaired glucose tolerance.; Impaired fasting glucose; Impaired glucose tolerance (oral); R73.01; R73.02

• Registration Number: IRCT20220902055858N1
• Lead Sponsor: Shahre-kord University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 21 November 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

Prediabetic Patient
Age 17 to 65 years
Not receiving blood sugar-lowering drugs

Exclusion Criteria

Known case of Diabetes
A history of urinary tract infection

Study & Design

• Study Type: interventional
• Study Design: Not specified